J&J slashes third-quarter profit by $3 billion over proposed opioid deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein
October 25, 2019 8:48 AM EDTBernstein analyst Lee Hambright highlights that Johnson & Johnson (NYSE: JNJ) has lost $23 billion in market cap since October 18th, when the company announced a voluntary baby powder recall (33,000 bottles) after the FDA found asbestos at 0.00002% concentration in a sample from a single bottle purchased... More
